A group of peptides from the salivary gland of the tick Hyalomma marginatum rufipes, a vector of Crimean Congo hemorrhagic fever show weak similarity to the madanins, a group of thrombin-inhibitory peptides from a second tick species, Haemaphysalis longicornis. We have evaluated the anti-serine protease activity of one of these H. marginatum peptides that has been given the name hyalomin-1. Hyalomin-1 was found to be a selective inhibitor of thrombin, blocking coagulation of plasma and inhibiting S2238 hydrolysis in a competitive manner with an inhibition constant (Ki) of 12 nM at an ionic strength of 150 mM. It also blocks the thrombin-mediated activation of coagulation factor XI, thrombin-mediated platelet aggregation, and the activation of coagulation factor V by thrombin. Hyalomin-1 is cleaved at a canonical thrombin cleavage site but the cleaved products do not inhibit coagulation. However, the C-terminal cleavage product showed non-competitive inhibition of S2238 hydrolysis. A peptide combining the N-terminal parts of the molecule with the cleavage region did not interact strongly with thrombin, but a 24-residue fragment containing the cleavage region and the C-terminal fragment inhibited the enzyme in a competitive manner and also inhibited coagulation of plasma. These results suggest that the peptide acts by binding to the active site as well as exosite I or the autolysis loop of thrombin. Injection of 2.5 mg/kg of hyalomin-1 increased arterial occlusion time in a mouse model of thrombosis, suggesting this peptide could be a candidate for clinical use as an antithrombotic.

Critical Care Medicine Department Clinical Center; National Institutes of Health Bethesda Maryland United States of America

Institute of Parasitology Academy of Sciences of the Czech Republic České Budejovice Czech Republic

Instituto de Bioquimica Médica Leopoldo de Meis Federal University of Rio de Janeiro Rio de Janeiro Brazil

Laboratory of Malaria and Vector Research NIAID National Institutes of Health Rockville Maryland United States of America

Research Technologies Branch National Institute of Allergy and Infectious Diseases National Institutes of Health Rockville Maryland United States of America

See more in PubMed

Bode W (2006) The structure of thrombin: a janus-headed proteinase. Semin Thromb Hemost 32 Suppl 1: 16–31. PubMed

Corral-Rodriguez MA, Macedo-Ribeiro S, Barbosa Pereira PJ, Fuentes-Prior P (2009) Tick-derived Kunitz-type inhibitors as antihemostatic factors. Insect Biochem Mol Biol 39: 579–595. 10.1016/j.ibmb.2009.07.003 PubMed DOI

Corral-Rodriguez MA, Macedo-Ribeiro S, Pereira PJ, Fuentes-Prior P (2010) Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications. J Med Chem 53: 3847–3861. 10.1021/jm901743x PubMed DOI

Huntington JA (2014) Natural inhibitors of thrombin. Thromb Haemost 111: 583–589. 10.1160/TH13-10-0811 PubMed DOI

Koh CY, Kini RM (2009) Molecular diversity of anticoagulants from haematophagous animals. Thromb Haemost 102: 437–453. 10.1160/TH09-04-0221 PubMed DOI

Rydel TJ, Tulinsky A, Bode W, Huber R (1991) Refined structure of the hirudin-thrombin complex. J Mol Biol 221: 583–601. PubMed

Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL, Fenton JW 2nd (1990) Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 29: 7095–7101. PubMed

van de Locht A, Stubbs MT, Bode W, Friedrich T, Bollschweiler C, et al. (1996) The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J 15: 6011–6017. PubMed PMC

Richardson JL, Kroger B, Hoeffken W, Sadler JE, Pereira P, et al. (2000) Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J 19: 5650–5660. PubMed PMC

Fuentes-Prior P, Noeske-Jungblut C, Donner P, Schleuning WD, Huber R, et al. (1997) Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A 94: 11845–11850. PubMed PMC

Koh CY, Kazimirova M, Nuttall PA, Kini RM (2009) Noncompetitive inhibitor of thrombin. Chembiochem 10: 2155–2158. 10.1002/cbic.200900371 PubMed DOI

Koh CY, Kazimirova M, Trimnell A, Takac P, Labuda M, et al. (2007) Variegin, a novel fast and tight binding thrombin inhibitor from the tropical bont tick. J Biol Chem 282: 29101–29113. PubMed

Koh CY, Kumar S, Kazimirova M, Nuttall PA, Radhakrishnan UP, et al. (2011) Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors. PLoS One 6: e26367 10.1371/journal.pone.0026367 PubMed DOI PMC

Figueiredo AC, de Sanctis D, Pereira PJ (2013) The tick-derived anticoagulant madanin is processed by thrombin and factor Xa. PLoS One 8: e71866 10.1371/journal.pone.0071866 PubMed DOI PMC

Iwanaga S, Okada M, Isawa H, Morita A, Yuda M, et al. (2003) Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis. Eur J Biochem 270: 1926–1934. PubMed

Francischetti IM, Anderson JM, Manoukis N, Pham VM, Ribeiro JM (2011) An insight into the sialotranscriptome and proteome of the coarse bontlegged tick, Hyalomma marginatum rufipes. J Proteomics 74: 2892–2908. 10.1016/j.jprot.2011.07.015 PubMed DOI PMC

Choi SH, Smith SA, Morrissey JH (2011) Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 118: 6963–6970. 10.1182/blood-2011-07-368811 PubMed DOI PMC

Francischetti IM, Valenzuela JG, Ribeiro JM (1999) Anophelin: kinetics and mechanism of thrombin inhibition. Biochemistry 38: 16678–16685. PubMed

Valenzuela JG, Francischetti IM, Ribeiro JM (1999) Purification, cloning, and synthesis of a novel salivary anti-thrombin from the mosquito Anopheles albimanus. Biochemistry 38: 11209–11215. PubMed

Myles T, Yun TH, Hall SW, Leung LL (2001) An extensive interaction interface between thrombin and factor V is required for factor V activation. J Biol Chem 276: 25143–25149. PubMed

Ma D, Mizurini DM, Assumpcao TC, Li Y, Qi Y, et al. (2013) Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo. Blood 122: 4094–4106. 10.1182/blood-2013-08-517474 PubMed DOI PMC

Alarcon-Chaidez FJ, Sun J, Wikel SK (2007) Transcriptome analysis of the salivary glands of Dermacentor andersoni Stiles (Acari: Ixodidae). Insect Biochem Mol Biol 37: 48–71. PubMed

Nakajima C, Imamura S, Konnai S, Yamada S, Nishikado H, et al. (2006) A novel gene encoding a thrombin inhibitory protein in a cDNA library from Haemaphysalis longicornis salivary gland. J Vet Med Sci 68: 447–452. PubMed

Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 96: 11023–11027. PubMed PMC

Rydel TJ, Yin M, Padmanabhan KP, Blankenship DT, Cardin AD, et al. (1994) Crystallographic structure of human gamma-thrombin. J Biol Chem 269: 22000–22006. PubMed

Monigatti F, Gasteiger E, Bairoch A, Jung E (2002) The Sulfinator: predicting tyrosine sulfation sites in protein sequences. Bioinformatics 18: 769–770. PubMed